In order to solve the bottleneck problems of"zero balance displacement"and"large variation of breastmilk"in the study of iodine EAR of pregnant women, lactating women and infants, firstly, this study intends to clarify the rate of metabolism and distribution of iodine during pregnancy by 125I tracer, SPECT/CT in vivo small animal imaging and γ counting study. Then, the iodine balance study in rats was conducted to verify the degree of "zero balance value displacement"caused by the difference of iodine absorption and store in different organs and tissues under different iodine exposure levels, so as to determine the iodine selection conditions of subjects in the population experiment. To determine the EAR of pregnant women by optimizing the population iodine balance experiment. Secondly, we proposed to study the regulatory mechanism of NIS and Pendrin in the mammary gland of lactating rats under different iodine nutrition levels to clarify the range of breastmilk iodine compensation. Mammary cell experiments intend to clarify the mutual regulations of iodine nutrition, oestrogen, and NIS and Pendrin. Based on the results of animal and cellular experiments, and the effect of genetic, oestrogen and iodine status were considered, a cross-sectional study of lactating women was conducted to determine the normal reference range of breastmilk iodine after screening out the people with abnormal indicators. This study will solve the bottleneck problems and difficulties in the iodine RNI research for pregnant women, lactating women and infants, found the iodine nutritional compensatory mechanism under special physiology, and provide the scientific basis for obtaining the accurate EAR basic data and the revision of iodine DRIs.
In this study, the absorption, distribution, storage and excretion of 125I in rats were observed by small animal imaging technology in vivo, so as to clarify the characteristics of iodine metabolism under different iodine exposure, and provide a basis for optimizing the experimental cycle of iodine balance experiment. The iodine balance experiment of rats during pregnancy was carried out, the iodine storage in different organs was detected to explain the phenomenon of "zero point balance value shift", and the population with iodine nutrition background was determined as the experimental objects in the iodine balance experiment. The optimized iodine balance experiment was further verified in the population, and the iodine EAR of pregnant women was explored to provide reference data for formulating the recommended iodine intake of pregnant women in China in the future. The expression difference of NIS and Pendrin in lactating rats with different iodine nutritional status was used to determine the range of milk iodine compensation. To determine the synergistic and independent effects of iodine level and estrogen on the expression of NIS and Pendrin in lactating mammary gland cells cultured in primary culture. Through a cross-section study of lactating women, the correlation between milk iodine level and NIS, Pendrin gene mutation, iodine exposure level and estrogen was discussed, the phenomenon of "huge milk iodine variation" was explained, the normal reference range of milk iodine was defined, and the basis was laid for further determination of iodine AI and EAR of lactating mothers in 0-6 months. To clarify the steady-state mechanism of iodine metabolism in pregnancy-milk during special physiological periods with different iodine exposure levels, research ideas and related research results can also provide references for the determination of other nutrient requirements.
Study Type
OBSERVATIONAL
Enrollment
1,200
During the iodine balance period of pregnant women, seaweed was added to lunch on the 4-6 days of the experiment, and the iodine content was about 200 μg.
Gansu Provincial Center for Disease Control and Prevention
Lanzhou, China
Xinjiang Uygur Autonomous Region Center for Disease Control and Prevention
Ürümqi, China
urine iodine concentration
μg/L
Time frame: pregnancy 1-40 weeks
Free thyroxine
pmol/L
Time frame: pregnancy 1-40 weeks
Free triiodothyronine
pmol/L
Time frame: pregnancy 1-40 weeks
Thyroglobulin(TG)
ug/L
Time frame: pregnancy 1-40 weeks
Thyroid-stimulating hormone
mIU/L
Time frame: pregnancy 1-40 weeks
Salt iodine concentration
μg/day
Time frame: pregnancy 1-40 weeks
Urinary iodine excretion
μg/day
Time frame: pregnancy 1-40 weeks
Fecal iodine excretion
μg/day
Time frame: pregnancy 1-40 weeks
Dietary iodine intake
μg/day
Time frame: pregnancy 1-40 weeks
Water iodine intake
ug/day
Time frame: pregnancy 1-40 weeks
Thyroid peroxidase antibody
IU/mL
Time frame: pregnancy 1-40 weeks
Thyroglobulin antibody
IU/mL
Time frame: pregnancy 1-40 weeks
Milk iodine excretion
μg/day
Time frame: Postpartum 0-6 months
Milk Iodine concentration
μg/L
Time frame: Postpartum 0-6 months
Thyroid volume
cm³
Time frame: Postpartum 0-6 months
Na+/I- symporter
mRNA
Time frame: Postpartum 0-6 months
Pendrin
mRNA
Time frame: Postpartum 0-6 months
estrogen
pmol/L
Time frame: Postpartum 0-6 months
progesterone
pmol/L
Time frame: Postpartum 0-6 months
oxytocin
ng/L
Time frame: Postpartum 0-6 months
prolactin
pg/MI
Time frame: Postpartum 0-6 months
Milk output
μg/day
Time frame: Postpartum 0-6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.